Volpara Health Technologies Ltd represents values of innovation, collaboration, and patient-centered care. As a leading provider of breast imaging analytics and technology, the company is dedicated to empowering healthcare providers with advanced solutions that improve early detection and treatment of breast cancer. Volpara's corporate philosophy is rooted in the belief that every woman should have access to personalized, high-quality breast care. By leveraging cutting-edge technology and a customer-centric approach, Volpara aims to reduce breast cancer mortality rates and enhance overall breast health. Volpara Health Technologies Ltd is committed to driving positive change in the healthcare industry through its values and dedication to improving patient outcomes.

Volpara Health Technologies Ltd is primarily present in countries such as the United States, Canada, Australia, New Zealand, Singapore, and the United Kingdom. These regions act as key markets for the company, where it focuses on providing advanced breast imaging analytics and solutions. Volpara's presence in these countries enables it to serve a wide range of healthcare providers and support breast cancer screening and early detection efforts globally.

Volpara Health Technologies Ltd has achieved significant milestones throughout its journey. Some notable accomplishments include expanding its global presence and customer base, launching cutting-edge products and services, and forging strategic partnerships with industry leaders. The company has consistently demonstrated its commitment to improving early detection and treatment outcomes for breast cancer, empowering healthcare providers with innovative solutions. Volpara Health Technologies Ltd has also made strides in research and development, continuously advancing its technology to enhance breast imaging and patient care. These milestones highlight the company's dedication to transforming the breast healthcare landscape and solidify its position as a leading player in the industry.

Volpara Health Technologies Ltd is a leading medical technology company specializing in breast imaging analytics and analysis software. Founded in 2009, Volpara has emerged as a key player in the field, providing innovative solutions for early detection and personalized breast cancer screening. The company's proprietary software, VolparaDensity, accurately measures breast tissue density, a significant risk factor for breast cancer. Volpara's advanced technologies enable healthcare professionals to make informed decisions about breast health, resulting in earlier diagnoses and improved patient outcomes. With a strong commitment to revolutionizing breast cancer screening, Volpara Health Technologies Ltd continues to set new standards in the industry.

The main competitors of Volpara Health Technologies Ltd in the market include Hologic Inc., GE Healthcare, and iCAD Inc.

Volpara Health Technologies Ltd primarily operates in the healthcare industry.

Volpara Health Technologies Ltd is an innovative healthcare company specializing in breast imaging analytics and software. As a leader in the field, Volpara aims to improve early detection of breast cancer through its advanced technology solutions. The company provides professional software and services that offer personalized assessments of breast density, image quality, and patient-specific risk. By empowering healthcare providers with accurate and objective data, Volpara is revolutionizing breast cancer screening and diagnosis. With its business model focused on delivering state-of-the-art solutions, Volpara Health Technologies Ltd strives to ensure better outcomes and enhanced patient care in the fight against breast cancer.

Volpara Health Technologies KGV ir -39,87.

Volpara Health Technologies KUV ir 8,33.

AlleAktien kvalitātes vērtējums Volpara Health Technologies ir 2/10.

gaidāmā Volpara Health Technologies apgrozījums ir 37,53 milj. NZD.

gaidāmā Volpara Health Technologies peļņa ir -7,84 milj. NZD.

Volpara Health Technologies specializes in diagnostic and medical imaging solutions for breast health. The company operates in various areas including software development, data analysis, medical imaging, and health provider information. Their main products include software solutions for breast cancer diagnosis, such as VolparaDensity for breast density analysis and VolparaEnterprise for preventive breast cancer diagnosis. Volpara also offers the VolparaLive service, which provides specialized medical support for breast health through remote monitoring. The company collaborates with healthcare professionals and organizations to improve patient care and aims to reduce cancer rates through better diagnostics and screening methods. Volpara's business model includes direct sales of software and services to hospitals, healthcare facilities, and clinics, as well as a partner program for healthcare industry companies. They offer their products and services globally and continuously improve their technology to meet the needs of patients and healthcare providers.

Volpara Health Technologies izmaksā dividendes 0 NZD, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt Volpara Health Technologies vai uzņēmums nedod dividendes.

Volpara Health Technologies ISIN ir NZVHTE0001S6.

Volpara Health Technologies WKN ir A2DVK1.

Volpara Health Technologies simbols ir VHT.AX.

Pēdējo 12 mēnešu laikā Volpara Health Technologies maksāja dividendes apmērā. Tas atbilst aptuveni dividendes ražībai. Nākamajos 12 mēnešos Volpara Health Technologies plāno maksāt dividendes 0 NZD apmērā.

Volpara Health Technologies pašreizējā dividendu rentabilitāte ir .

Volpara Health Technologies maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos .

Volpara Health Technologies pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 NZD. Tas atbilst dividendes ražībai 0 %.

Volpara Health Technologies tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu Volpara Health Technologies apmērā 0 NZD, kas tika izmaksāta 7.10.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 7.10.2024..

Pēdējās dividendes izmaksa notika 7.10.2024..

Gadā 2023, Volpara Health Technologies izmaksāja 0 NZD dividendes.

Volpara Health Technologies dividendes tiek izmaksātas NZD.